Radiopharmaceuticals
Brand Name
PDvue Injection

Active Pharmaceutical Ingredient
Fluoropropyl-CIT (18F)

Indication and Usage
PDvue Injection is indicated in positron emission tomography (PET)
imaging for diagnosis of Parkinson's disease by measuring the density
of dopamine transporters in the striatum.

Dosage and Administration
Administer 185 MBq (5 mCi) as an intravenous injection for an adult with
suspected Parkinson’s disease.
Brand Name
Alzavue Injection

Active Pharmaceutical Ingredient
Florapronol (18F)

Indication and Usage
Alzavue Injection is a radioactive diagnostic agent indicated for Positron
Emission Tomography (PET) imaging of the brain to estimate β amyloid
neuritic plaque density in adult patients with cognitive impairment who are
being evaluated for Alzheimer’s disease (AD) or other causes of cognitive
decline.

Dosage and Administration
Administer 370 MBq (10 mCi) as an intravenous injection.
Brand Name
FutureChem FDG Injection

Active Pharmaceutical Ingredient
Fludeoxyglucose (18F)

Indication and Usage
FutureChem FDG Injection is indicated in positron emission tomography
(PET) imaging for diagnosis of cancers, coronary artery disease, left
ventricular dysfunction and epilepsy

Dosage and Administratio
The recommended dose of FutureChem FDG Injection for an adult (70 kg)
is 185-370 MBq(5-10 mCi), as an intravenous injection.

Brand Name
FutureChem FLT Injection

Active Pharmaceutical Ingredient
Fluorothymidine (18F)


Indication and Usage
FutureChem FLT Injection is indicated in positron emission tomography (PET)
imaging for patients diagnosed or suspected with lung cancer to determine

the proliferation of malignant cells.


Dosage and Administration

The recommended dose of FutureChem FLT Injection for an adult
is 185-370 MBq(5-10 mCi), as an intravenous injection.